ACHC - Company ID 0001520697
The table below shows Acadia Healthcare Company, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B | $2.09B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $177.60M |
Acadia Healthcare Company, Inc. reported annual revenue of $3.31B for fiscal year 2025. That is up 5.0% from $3.15B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.81B (FY 2016) to $3.31B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $156.80M |
| $153.30M |
| $124.30M |
| $108.20M |
| $97.80M |
| Operating income | - | - | - | - | - | - |
| Income tax | $25.98M | $77.39M | -$9.70M | $94.11M | $67.56M | $40.61M |
| Net income | -$1.10B | $255.61M | -$21.67M | $273.14M | $190.63M | -$672.13M |
| EPS (diluted) | -$12.16 | $2.78 | -$0.24 | $2.98 | $2.10 | -$7.59 |